tiprankstipranks
Trending News
More News >
Towa Pharmaceutical Co (JP:4553)
:4553
Advertisement

Towa Pharmaceutical Co (4553) Price & Analysis

Compare
0 Followers

4553 Stock Chart & Stats


Towa Pharmaceutical Co News

4553 FAQ

What was Towa Pharmaceutical Co ’s price range in the past 12 months?
Towa Pharmaceutical Co lowest stock price was ¥2298.00 and its highest was ¥3415.00 in the past 12 months.
    What is Towa Pharmaceutical Co ’s market cap?
    Towa Pharmaceutical Co ’s market cap is ¥145.08B.
      When is Towa Pharmaceutical Co ’s upcoming earnings report date?
      Towa Pharmaceutical Co ’s upcoming earnings report date is Nov 17, 2025 which is in 95 days.
        How were Towa Pharmaceutical Co ’s earnings last quarter?
        Towa Pharmaceutical Co released its earnings results on Aug 07, 2025. The company reported ¥51.06 earnings per share for the quarter, missing the consensus estimate of ¥63.464 by -¥12.404.
          Is Towa Pharmaceutical Co overvalued?
          According to Wall Street analysts Towa Pharmaceutical Co ’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
            Does Towa Pharmaceutical Co pay dividends?
            Towa Pharmaceutical Co pays a Semiannually dividend of ¥40 which represents an annual dividend yield of 2.12%. See more information on Towa Pharmaceutical Co dividends here
              What is Towa Pharmaceutical Co ’s EPS estimate?
              Towa Pharmaceutical Co ’s EPS estimate is 62.02.
                How many shares outstanding does Towa Pharmaceutical Co have?
                Towa Pharmaceutical Co has 51,516,000 shares outstanding.
                  What happened to Towa Pharmaceutical Co ’s price movement after its last earnings report?
                  Towa Pharmaceutical Co reported an EPS of ¥51.06 in its last earnings report, missing expectations of ¥63.464. Following the earnings report the stock price went down -2.489%.
                    Which hedge fund is a major shareholder of Towa Pharmaceutical Co ?
                    Currently, no hedge funds are holding shares in JP:4553

                    Company Description

                    Towa Pharmaceutical Co

                    Towa Pharmaceutical Co., Ltd. is a leading Japanese company engaged in the research, development, manufacturing, and distribution of generic pharmaceutical products. The company primarily focuses on providing high-quality, cost-effective generic drugs across various therapeutic areas, aiming to enhance accessibility to essential medications. With a commitment to innovation and quality, Towa Pharmaceutical serves both domestic and international markets, contributing to healthcare sustainability.

                    Towa Pharmaceutical Co (4553) Earnings & Revenues

                    4553 Stock 12 Month Forecast

                    Average Price Target

                    ¥3,543.38
                    ▲(20.20% Upside)
                    {"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"2043":"¥2,043","4156":"¥4,156","2571.25":"¥2,571.3","3099.5":"¥3,099.5","3627.75":"¥3,627.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":4155.9202813752,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">¥4.16K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":3543.3763188876,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">¥3.54K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":3207.7960140798,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">¥3.21K</span>\n  </div></div>","useHTML":true}}],"tickPositions":[2043,2571.25,3099.5,3627.75,4156],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jun<br/>2021","6":"Sep<br/>2021","9":"Nov<br/>2024","12":"May<br/>2025","25":"May<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,2620,2738.1477139519384,2856.2954279038768,2974.443141855815,3092.590855807754,3210.7385697596924,3328.8862837116308,3447.033997663569,3565.1817116155075,3683.3294255674464,3801.4771395193848,3919.624853471323,4037.7725674232615,{"y":4155.9202813752,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,2620,2691.0289476067383,2762.057895213477,2833.086842820215,2904.115790426954,2975.144738033692,3046.173685640431,3117.202633247169,3188.231580853908,3259.260528460646,3330.289476067385,3401.318423674123,3472.347371280862,{"y":3543.3763188876,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,2620,2665.2150780061384,2710.4301560122767,2755.6452340184155,2800.860312024554,2846.0753900306922,2891.2904680368306,2936.5055460429694,2981.7206240491078,3026.935702055246,3072.1507800613845,3117.3658580675233,3162.5809360736616,{"y":3207.7960140798,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":2044.563,"date":1614556800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":2044.563,"date":1617235200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":2058.212,"date":1619827200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":2190.149,"date":1622505600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":2497.697,"date":1625097600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":2625.085,"date":1627776000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":2788.869,"date":1630454400000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":2788.869,"date":1630454400000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":2707.598,"date":1635724800000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":3040.897,"date":1730419200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":2971.897,"date":1738368000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":2700,"date":1743465600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":2620,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
                    Similar Stocks
                    Company
                    Price & Change
                    Follow
                    KYORIN Pharmaceutical Co.,Ltd.
                    SAWAI GROUP HOLDINGS Co., Ltd.
                    Kissei Pharmaceutical Co
                    Kaken Pharmaceutical Co
                    Torii Pharmaceutical Co

                    Ownership Overview

                    7.40%90.00%
                    Insiders
                    7.40%
                    Mutual Funds
                    ― Other Institutional Investors
                    90.00% Public Companies and
                    Individual Investors

                    Options Prices

                    Currently, No data available
                    ---
                    Popular Stocks
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis